The Potential Applications of Peroxisome Proliferator-Activated Receptor δ Ligands in Assisted Reproductive Technology

Vitale, S. G., Laganà, A. S., Nigro, A., Rosa, V. L. L., Rossetti, P., Rapisarda, A. M. C., Vignera, S. L., Condorelli, R. A., Corrado, F., Buscema, M., & D'Annaa, R. (2016). Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions. PPAR Research, 2016(), 222-230. https://doi.org/10.1155/2016/6517313
A.Monsalve, F., Pyarasani, R. D., Lopez, F. D., & Carrasco, R. M. (2013). Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases. Mediators of Inflammation, 2013(), 1001-1018-191. https://doi.org/10.1155/2013/549627
Chao, C. Y., & Huang, C. J. (2008). In Vitro Activation of Peroxisome Proliferator Activated Receptor α by Some Extracts from Food Materials. 藥物食品分析, 16(4), 62-69. https://www.airitilibrary.com/Article/Detail?DocID=10219498-200808-16-4-62-69-a
Peng, Y. H. (2010). Structure based drug design of peroxisome proliferator-activated receptor (PPAR) agonists [doctoral dissertation, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-2203201110475929
Ren, P., Zhang, Y. Q., Huang, Y., Yang, Y. L., & Jiang, M. (2015). Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders. Clinical Medicine Insights: Oncology, (), 43-49. https://doi.org/10.4137/CMO.S23527